ArticleScientific reports2025
Comparative evaluation of moutan pods and moutan barks by HPLC-DAD-ESI-MS/MS technique.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pharmacological Effects and Development Prospects of the Main Active Compounds ofMolecules (Basel, Switzerland) · 2026Review
- Quality Evaluation of the Root Bark Epidermis of Peony by HPLC-DAD-ESI-MS/MS.Molecules (Basel, Switzerland) · 2026Article
- Tentative Identification of Chemical Constituents in Liuwei Dihuang Pills Based on UPLC-Orbitrap-MS.Metabolites · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
To evaluate the development and application of a kind of oil peony by chromatographic analysis of the main active components of the waste moutan pods (MP).The methods adopted in this paper, firstly, the quality evaluation method of MP is established by HPLC-DAD-ESI-MS/MS; The second is to compare the types and contents of the main active components of moutan barks (Chinese Pharmacopoeia, MB) with those of the medicinal parts of peony used in oil. HPLC fingerprint method for the extract of moutan pods (EMP) was established. Twenty-one compounds were identified in EMP and their levels determined in EMP and the extract of moutan barks (EMB) by HPLC. The results showed that the components of EMP and EMB were similar, though their contents differed. These findings suggest that EMP may have similar pharmacological effects to EMB. Our findings regarding the similarity and comparison of the chemical components in the EMB and EMP have important practical value for replacing EMB medicine and protecting peony plants from resource depletion caused by root digging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.